This is an increase from the 55 treatments and 38 vaccine candidates identified when the Institute first started tracking treatments and vaccines in early March.
Of these, nine vaccines and more than 50 treatments currently are in clinical trials. These include the RECOVERY study, the World Health Organization's Solidarity Study, the National Institute of Allergy and Infectious Diseases' Adaptive COVID-19 Treatment Trial, and the REMAP-CAP trial.
A new, interactive version of the tracker makes the data searchable and sortable. Graphics capture the progress made, and the raw data can also be downloaded offline in a useable spreadsheet format. The tracker is updated regularly.
The COVID-19 Treatment and Vaccine Tracker is produced and maintained by FasterCures, with input from its Advisory Council, which includes three former FDA chiefs, a Nobel Laureate biologist, and key industry leaders.
The information is compiled by publicly-available information from validated sources.
The Milken Institute is a nonprofit, nonpartisan think tank.
Inimmune signs research collaboration with Boston Children's Hospital
ResVita Bio receives USD250,000 phase one Small Business Innovation Research grant from NIAID
Phase II Data of Oral Dexpramipexole Published in Eosinophilic Asthma
AllerVie Health Rebrands Southern Allergy & Asthma
Applied BioCode Inks Distribution Agreement with Medline Industries
Vedanta Biosciences Receives Fast Track Designation for VE303
KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
French Ophthalmology Specialist Horus Pharma Group Launches a Nordic Subsidiary